ALLIANCEBERNSTEIN L.P. - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 101 filers reported holding ENDOLOGIX INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$72,000
-66.7%
100,457
-11.1%
0.00%
Q3 2018$216,000
-66.2%
113,0570.0%0.00%
Q2 2018$640,000
+36.2%
113,057
+1.7%
0.00%
Q1 2018$470,000
-15.5%
111,157
+6.9%
0.00%
Q4 2017$556,000
+14.6%
103,957
-4.4%
0.00%
Q3 2017$485,000
-8.3%
108,7570.0%0.00%
Q2 2017$529,000
-25.1%
108,757
+11.5%
0.00%
-100.0%
Q1 2017$706,000
-17.4%
97,557
-34.8%
0.00%0.0%
Q4 2016$855,000
-55.3%
149,5570.0%0.00%
-50.0%
Q3 2016$1,914,000
+2.7%
149,5570.0%0.00%0.0%
Q2 2016$1,863,000
+105.2%
149,557
+37.8%
0.00%
+100.0%
Q1 2016$908,000
-19.9%
108,557
-5.2%
0.00%0.0%
Q4 2015$1,134,000
-21.9%
114,557
-3.3%
0.00%0.0%
Q3 2015$1,452,000
-18.2%
118,470
+2.4%
0.00%0.0%
Q2 2015$1,774,000
-10.0%
115,657
+0.2%
0.00%
-50.0%
Q1 2015$1,971,000
+8.0%
115,457
-3.3%
0.00%0.0%
Q4 2014$1,825,000
+44.3%
119,3570.0%0.00%
+100.0%
Q3 2014$1,265,000
-30.3%
119,3570.0%0.00%
-50.0%
Q2 2014$1,815,000
+18.2%
119,357
-0.0%
0.00%
+100.0%
Q1 2014$1,536,000
-56.1%
119,385
-40.4%
0.00%
-66.7%
Q4 2013$3,495,000
+8.1%
200,407
+0.0%
0.00%0.0%
Q3 2013$3,232,000
+20.8%
200,387
-0.5%
0.00%0.0%
Q2 2013$2,675,000201,3980.00%
Other shareholders
ENDOLOGIX INC shareholders Q3 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 2,514,936$31,644,00011.52%
Tamarack Capital Management, LLC 3,300,000$34,980,0007.75%
GREAT POINT PARTNERS LLC 973,200$10,316,0004.43%
First Light Asset Management, LLC 231,599$2,455,0001.68%
Iguana Healthcare Management, LLC 182,500$1,935,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,501,526$26,516,0000.97%
ArrowMark Colorado Holdings LLC 2,669,602$28,298,0000.78%
WASHINGTON CAPITAL MANAGEMENT, INC 174,894$1,854,0000.73%
Rhenman & Partners Asset Management AB 200,000$2,120,0000.62%
PALISADE CAPITAL MANAGEMENT, LP 2,200,411$23,324,0000.59%
View complete list of ENDOLOGIX INC shareholders